Clinical Research Associates’ (CRA) goals are to better understand the causes of autism, accelerate translational and clinical research, and improve the lives of individuals with autism.
The primary activity of CRA is to enable the development of new treatments and supports for individuals with ASD and their families.
CRA’s immediate aim is to develop more reliable quantitative, objective outcome measures for ASD clinical trials; to develop biomarkers to stratify ASD patients and demonstrate efficacy of treatments; to develop partnerships with individuals with ASD and clinical providers to promote ASD research; and to evaluate new potential therapies for ASD, including R-baclofen (arbaclofen, STX209) and other drugs.
Clinical Research Associates, L.L.C. is an affiliate of the Simons Foundation.
See the CRA Staff here.